Literature DB >> 32861468

Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia.

Harapan Harapan1, Abram L Wagner2, Amanda Yufika3, Abdul M Setiawan4, Samsul Anwar5, Sri Wahyuni6, Febrivan W Asrizal7, Muhammad R Sufri8, Reza P Putra9, Nanda P Wijayanti10, Salwiyadi Salwiyadi11, Razi Maulana12, Afriyani Khusna13, Ina Nusrina14, Muhammad Shidiq15, Devi Fitriani16, Muharrir Muharrir9, Cut A Husna17, Fitria Yusri6, Reza Maulana9, Yogambigai Rajamoorthy18, David Alexander Groneberg19, Ruth Müller20, Mudatsir Mudatsir21.   

Abstract

BACKGROUND: A clinical trial is ongoing to evaluate the safety and efficacy of a monkeypox vaccine among healthcare workers (HCWs). The critical question that needs to be addressed is whether HCWs are willing to accept and purchase this vaccine. The objective of this study was to evaluate the acceptance and willingness to pay (WTP) for the vaccine among HCWs.
METHODS: From May to July 2019, a cross-sectional study was conducted among registered general practitioners (GPs) in Indonesia. A contingent valuation method was employed to evaluate the WTP. Besides acceptance and WTP, various explanatory variables were also collected and assessed. A logistic regression and a multivariable linear regression were used to explore the explanatory variables influencing acceptance and WTP, respectively.
RESULTS: Among 407 respondents, 391 (96.0%) expressed acceptance of a free vaccination. The mean and median WTP was US$ 37.0(95%CI:US$ 32.76-US$ 41.23) and US$ 17.90(95%CI:US$ 17.90-US$ 17.90), respectively. In an unadjusted analysis, those 30 years old or younger had 2.94 times greater odds of vaccine acceptance compared to those who were older (95%CI: 1.07-8.08). Location of alma mater, type of workplace, length of individual medical experience, and monthly income of GPs were all significantly associated with WTP.
CONCLUSION: Although the vast majority of GPs would accept a freely provided vaccine, they were also somewhat price sensitive. This finding indicates that partial subsidy maybe required to achieve high vaccine coverage, particularly among GPs at community health centres or those with a shorter duration of medical practice.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Indonesia; Monkeypox; Prevention; Vaccine acceptance; Willingness to pay

Mesh:

Substances:

Year:  2020        PMID: 32861468     DOI: 10.1016/j.vaccine.2020.08.034

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  4 in total

1.  On willingness to pay for Covid-19 vaccines: a case study from India.

Authors:  Upasak Das; Udayan Rathore; Rupayan Pal
Journal:  Hum Vaccin Immunother       Date:  2021-11-10       Impact factor: 3.452

2.  Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?

Authors:  Ranjan K Mohapatra; Hardeep Singh Tuli; Ashish K Sarangi; Sandip Chakraborty; Deepak Chandran; Chiranjib Chakraborty; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-06-11       Impact factor: 13.400

3.  When a Neglected Tropical Disease Goes Global: Knowledge, Attitudes and Practices of Italian Physicians towards Monkeypox, Preliminary Results.

Authors:  Matteo Riccò; Pietro Ferraro; Vincenzo Camisa; Elia Satta; Alessandro Zaniboni; Silvia Ranzieri; Antonio Baldassarre; Salvatore Zaffina; Federico Marchesi
Journal:  Trop Med Infect Dis       Date:  2022-07-14

Review 4.  Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis.

Authors:  Jonny Karunia Fajar; Malik Sallam; Gatot Soegiarto; Yani Jane Sugiri; Muhammad Anshory; Laksmi Wulandari; Stephanie Astrid Puspitasari Kosasih; Muhammad Ilmawan; Kusnaeni Kusnaeni; Muhammad Fikri; Frilianty Putri; Baitul Hamdi; Izza Dinalhaque Pranatasari; Lily Aina; Lailatul Maghfiroh; Fernanda Septi Ikhriandanti; Wa Ode Endiaverni; Krisna Wahyu Nugraha; Ory Wiranudirja; Sally Edinov; Ujang Hamdani; Lathifatul Rosyidah; Hanny Lubaba; Rinto Ariwibowo; Riska Andistyani; Ria Fitriani; Miftahul Hasanah; Fardha Ad Durrun Nafis; Fredo Tamara; Fitri Olga Latamu; Hendrix Indra Kusuma; Ali A Rabaan; Saad Alhumaid; Abbas Al Mutair; Mohammed Garout; Muhammad A Halwani; Mubarak Alfaresi; Reyouf Al Azmi; Nada A Alasiri; Abeer N Alshukairi; Kuldeep Dhama; Harapan Harapan
Journal:  Vaccines (Basel)       Date:  2022-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.